The management of stage T1 grade 3 transitional cell carcinoma of the bladder.
Evans
C P
CP
Department of Urology, University of California, Davis, Sacramento, California 95817, USA. cpevans@ucdavis.edu
Busby
J E
JE
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000473:pathology / Q000628:therapy*; D015653:Cystectomy / Q000379:methods; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D009367:Neoplasm Staging / Q000379:methods; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000628:therapy*
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D007372:Interferons